Fueled by $143M fundraise, Cincy startup doses first patient in new clinical trial
December 10, 2021 at 13:14 PM EST
A Cincinnati startup developing treatments for hypertension and other cardio-renal diseases has dosed its first patient in a new clinical trial fueled by a recent $143 million fundraise.
